367 related articles for article (PubMed ID: 32892355)
61. Investigating the Association Between Verbal Forgetting and Pathological Markers of Alzheimer's and Lewy Body Diseases.
Schaeffer MJ; Callahan BL;
J Alzheimers Dis; 2019; 70(3):877-887. PubMed ID: 31282412
[TBL] [Abstract][Full Text] [Related]
62. High discriminatory ability of peripheral and CFSF biomarkers in Lewy body diseases.
Bougea A; Stefanis L; Emmanouilidou E; Vekrelis K; Kapaki E
J Neural Transm (Vienna); 2020 Mar; 127(3):311-322. PubMed ID: 31912280
[TBL] [Abstract][Full Text] [Related]
63. A soluble tau fragment generated by caspase-2 is associated with dementia in Lewy body disease.
Smith BR; Nelson KM; Kemper LJ; Leinonen-Wright K; Petersen A; Keene CD; Ashe KH
Acta Neuropathol Commun; 2019 Jul; 7(1):124. PubMed ID: 31362787
[TBL] [Abstract][Full Text] [Related]
64. Limbic neuropathology in idiopathic Parkinson's disease with concomitant dementia.
Bertrand E; Lechowicz W; Szpak GM; Lewandowska E; Dymecki J; Wierzba-Bobrowicz T
Folia Neuropathol; 2004; 42(3):141-50. PubMed ID: 15535032
[TBL] [Abstract][Full Text] [Related]
65. Entorhinal Tau Pathology, Episodic Memory Decline, and Neurodegeneration in Aging.
Maass A; Lockhart SN; Harrison TM; Bell RK; Mellinger T; Swinnerton K; Baker SL; Rabinovici GD; Jagust WJ
J Neurosci; 2018 Jan; 38(3):530-543. PubMed ID: 29192126
[TBL] [Abstract][Full Text] [Related]
66. Alzheimer's disease, Lewy body disease and aging: a comparative study of the perforant pathway.
Lippa CF; Pulaski-Salo D; Dickson DW; Smith TW
J Neurol Sci; 1997 Apr; 147(2):161-6. PubMed ID: 9106122
[TBL] [Abstract][Full Text] [Related]
67. Pathology and temporal onset of visual hallucinations, misperceptions and family misidentification distinguishes dementia with Lewy bodies from Alzheimer's disease.
Ferman TJ; Arvanitakis Z; Fujishiro H; Duara R; Parfitt F; Purdy M; Waters C; Barker W; Graff-Radford NR; Dickson DW
Parkinsonism Relat Disord; 2013 Feb; 19(2):227-31. PubMed ID: 23182311
[TBL] [Abstract][Full Text] [Related]
68. The limbic and neocortical contribution of α-synuclein, tau, and amyloid β to disease duration in dementia with Lewy bodies.
Ferman TJ; Aoki N; Crook JE; Murray ME; Graff-Radford NR; van Gerpen JA; Uitti RJ; Wszolek ZK; Graff-Radford J; Pedraza O; Kantarci K; Boeve BF; Dickson DW
Alzheimers Dement; 2018 Mar; 14(3):330-339. PubMed ID: 29100980
[TBL] [Abstract][Full Text] [Related]
69. Spatial proteomics of hippocampal subfield-specific pathology in Alzheimer's disease and primary age-related tauopathy.
Walker JM; Orr ME; Orr TC; Thorn EL; Christie TD; Yokoda RT; Vij M; Ehrenberg AJ; Marx GA; McKenzie AT; Kauffman J; Selmanovic E; Wisniewski T; Drummond E; White CL; Crary JF; Farrell K; Kautz TF; Daoud EV; Richardson TE
Alzheimers Dement; 2024 Feb; 20(2):783-797. PubMed ID: 37777848
[TBL] [Abstract][Full Text] [Related]
70. Associations Between Amyloid and Tau Pathology, and Connectome Alterations, in Alzheimer's Disease and Mild Cognitive Impairment.
King-Robson J; Wilson H; Politis M;
J Alzheimers Dis; 2021; 82(2):541-560. PubMed ID: 34057079
[TBL] [Abstract][Full Text] [Related]
71. Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases.
Pletnikova O; West N; Lee MK; Rudow GL; Skolasky RL; Dawson TM; Marsh L; Troncoso JC
Neurobiol Aging; 2005; 26(8):1183-92. PubMed ID: 15917102
[TBL] [Abstract][Full Text] [Related]
72. The value of cerebrospinal fluid α-synuclein and the tau/α-synuclein ratio for diagnosis of neurodegenerative disorders with Lewy pathology.
Førland MG; Tysnes OB; Aarsland D; Maple-Grødem J; Pedersen KF; Alves G; Lange J
Eur J Neurol; 2020 Jan; 27(1):43-50. PubMed ID: 31293044
[TBL] [Abstract][Full Text] [Related]
73. Effects of Alzheimer and Lewy Body Disease Pathologies on Brain Metabolism.
Lee YG; Jeon S; Park M; Kang SW; Yoon SH; Baik K; Lee PH; Sohn YH; Ye BS;
Ann Neurol; 2022 Jun; 91(6):853-863. PubMed ID: 35307860
[TBL] [Abstract][Full Text] [Related]
74. Lewy Body Pathology and Chronic Traumatic Encephalopathy Associated With Contact Sports.
Adams JW; Alvarez VE; Mez J; Huber BR; Tripodis Y; Xia W; Meng G; Kubilus CA; Cormier K; Kiernan PT; Daneshvar DH; Chua AS; Svirsky S; Nicks R; Abdolmohammadi B; Evers L; Solomon TM; Cherry JD; Aytan N; Mahar I; Devine S; Auerbach S; Alosco ML; Nowinski CJ; Kowall NW; Goldstein LE; Dwyer B; Katz DI; Cantu RC; Stern RA; Au R; McKee AC; Stein TD
J Neuropathol Exp Neurol; 2018 Sep; 77(9):757-768. PubMed ID: 30053297
[TBL] [Abstract][Full Text] [Related]
75. Pyroglutamylated amyloid-β is associated with hyperphosphorylated tau and severity of Alzheimer's disease.
Mandler M; Walker L; Santic R; Hanson P; Upadhaya AR; Colloby SJ; Morris CM; Thal DR; Thomas AJ; Schneeberger A; Attems J
Acta Neuropathol; 2014 Jul; 128(1):67-79. PubMed ID: 24861310
[TBL] [Abstract][Full Text] [Related]
76. Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology.
Vaikath NN; Majbour NK; Paleologou KE; Ardah MT; van Dam E; van de Berg WD; Forrest SL; Parkkinen L; Gai WP; Hattori N; Takanashi M; Lee SJ; Mann DM; Imai Y; Halliday GM; Li JY; El-Agnaf OM
Neurobiol Dis; 2015 Jul; 79():81-99. PubMed ID: 25937088
[TBL] [Abstract][Full Text] [Related]
77. Changes in CD200 and intercellular adhesion molecule-1 (ICAM-1) levels in brains of Lewy body disorder cases are associated with amounts of Alzheimer's pathology not α-synuclein pathology.
Walker DG; Lue LF; Tang TM; Adler CH; Caviness JN; Sabbagh MN; Serrano GE; Sue LI; Beach TG
Neurobiol Aging; 2017 Jun; 54():175-186. PubMed ID: 28390825
[TBL] [Abstract][Full Text] [Related]
78. Cognition at Each Stage of Lewy Body Disease with Co-occurring Alzheimer's Disease Pathology.
Ryman SG; Yutsis M; Tian L; Henderson VW; Montine TJ; Salmon DP; Galasko D; Poston KL
J Alzheimers Dis; 2021; 80(3):1243-1256. PubMed ID: 33646154
[TBL] [Abstract][Full Text] [Related]
79. It Is Time to Study Overlapping Molecular and Circuit Pathophysiologies in Alzheimer's and Lewy Body Disease Spectra.
Wakasugi N; Hanakawa T
Front Syst Neurosci; 2021; 15():777706. PubMed ID: 34867224
[TBL] [Abstract][Full Text] [Related]
80. An evaluation of the impact of MAPT, SNCA and APOE on the burden of Alzheimer's and Lewy body pathology.
Wider C; Ross OA; Nishioka K; Heckman MG; Vilariño-Güell C; Jasinska-Myga B; Erketin-Taner N; Rademakers R; Graff-Radford NR; Mash DC; Papapetropoulos S; Duara R; Uchikado H; Wszolek ZK; Farrer MJ; Dickson DW
J Neurol Neurosurg Psychiatry; 2012 Apr; 83(4):424-9. PubMed ID: 22291217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
